Curis Inc - Company Profile
Powered by 
All the sales intelligence you need on Curis Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Curis Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Curis Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on Curis Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Curis Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Martyn D. Greenacre
Chairman Executive BoardMr. Martyn D. Greenacre has been the Chairman of the company since 2017. Prior to this, he served as a Director at Curis. Previously, he served as a Director at Creative BioMolecules Inc; Chairman of Life Mist LLC; and Chief Executive Officer of Delsys Pharmaceutical Corporation. Mr. Greenacre also served as the President and Chief Executive Officer of Zynaxis, Inc. from 1993 to 1997; and Director of Cephalon Inc.
James E. Dentzer
President; Director; Chief Executive Officer Executive BoardMr. James E. Dentzer has been the Chief Executive Officer, Director, and President of the company since 2018. Prior to this, he served as the Chief Operating Officer and Chief Financial Officer of the company from March 2018 to September 2018. Previously, he served as the Chief Financial Officer of Dicerna Pharmaceuticals Inc and he held the same position at Valeritas, Inc. from March 2010 to December 2013. Mr. Dentzer also served as the Chief Financial Officer at Amicus Therapeutics, Inc. from October 2006 to October 2009.
Diantha Duvall
Chief Financial Officer Senior ManagementMs. Diantha Duvall has been the Chief Financial Officer of the company since 2022. Prior to this, she served as the Chief Financial Officer of Genocea Biosciences. Previously, she served as the Vice President, Finance and Chief Accounting Officer of Bioverativ, Inc. Ms. Duvall also served as the Commercial Controller and U.S. Commercial Controller at Biogen.
Robert Martell, M.D., Ph.D.
Chief Scientific Officer Senior ManagementMr. Robert Martell has been the Chief Scientific Officer of the company since 2023. Prior to this, he served as the company's Head of Research and Development from 2018 to 2023. Previously, he served as the Chief Medical Officer of MethylGene and Tesaro. Mr. Martell has also held various leadership positions at Bristol-Myers Squibb and Bayer.
Jonathan Zung, Ph.D.
Chief Development Officer Senior ManagementMr. Jonathan Zung has been the Chief Development Officer of the company since 2023. Prior to this, he served as the Chief Development Officer of Evelo Biosciences. Previously, he held various leadership roles at WCG, Covance, UCB, BMS and Pfizer.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer